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Introduction

With the profound advances offered the field of infectious diseases
by advances in immunology, and with the later knowledge that immunologic
phenomena are not restricted to bacterial substances, it is not surpris¬
ing that workers in neoplastic diseases should devote much time and energy
to the application of these phenomena to cancer.

However, despite an

enormous amount of work, there is as yet no unanimous agreement on the
fundamental question, "Do specific cancer antibodies exist?"

Thus, one

experienced worker claims (30), "There is no antibody whose existence is
more definitely proved than those of these antimalignant-cell antibodies,"
xvhile another writer asserts (51) "The demonstration of specific anti¬
cancer cell substances in the blood of cancer immune animals is not gen¬
erally accepted."

In view of the complicated antigenic pattern of neo¬

plastic tissue, such disagreement is not surprising.
The preparation of malignant cells' antibodies according to Mann and
Welker (34) is hampered by the presence of blood in the tumor antigen.
This would cause the production of antibodies to the blood proteins as
well as to the malignant cells.

By adsorbing the antigen on to alumina

and injecting the suspension intramuscularly into rabbits these workers
prepared antisera in which the blood protein antibody became undetectable,
\vhile malignant cells' antibody remained.

The experiments described here¬

in were performed to confirm, and, if possible,extend this vrork.
Among the workers who have obtained evidence for the existence of
carcinoma antibodies is Lumsden, who, in 1925 (29), showed that repeated
injection into rats of mouse tumor tissue produced antisera which pre¬
vented in vitro growth of tumor cells, but not that of other tissue cells.
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Later, he and his associates (32) immunized rats against Jensen rat sar¬
coma and found their sera toxic to malignant cells of any variety, while
harmless to normal tissue.

Hirszfeld and Halber (20) found that rabbits

injected with alcoholic extracts of cancer tissue produced antibodies
which reacted with more than half of all tumors tested, while these anti¬
bodies failed to react with normal tissues.

Morelli (39) injected ani¬

mals with thyroid cancer, both primary and metastatic to the abdomen,
and found that the sera of more than half the animals reacted with the
alcoholic extract of homologous tumor.
with extract of mammary carcinoma.

In one case, the serum reacted

Fuchs (12) found that after intra¬

venous injection of a cell free tumor antigen, normal persons develop
an antibody, common to all malignant neoplasms, which gradually disap¬
pears from the blood in a few months.

Attempting to break down the anti¬

genic pattern of malignant tissue into more specific groups, LehmannFacius (27) found that the phosphatid fraction of carcinoma extract could
be separated into two parts, one of which was strongly separated by spe¬
cific carcinoma phosphatid antiserum, and the other by fatty acid anti¬
serum.

On the basis of his work, Aron (5) concluded that alcoholic ex¬

tract of urine of cancer patients contained an antigenic principle which
gave a precipitin reaction "when mixed in suitable proportions with sera
from cancer patients.

Trawinski (54) injected saline extracts of fresh

tumor tissue into rabbits intravenously and produced organ and tumor
specific precipitins reacting with the antigen, while the sera of rabbits
immunized with normal tissue did not react with the malignant antigen.
Working with well standardized animal tumors, Hoyle (23) found that the
alcoholic extracts of several types gave positive complement-fixation
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tests with the sera of animals bearing these tumors.

The antigen appeared

to be lipoidal, and was thought to be common for the different tumors.
Furthermore, the many serological tests for malignant disease, based upon
antigen-antibody reactions (discussed below), are suggestive enough to af¬
ford additional evidence for the existence of these substances.
On the other hand, other experiments have failed to reveal specific
malignant cells' antibodies, but indicated the antibody was common to all
tissues of the particular animal species, and was non-specific for tissue.
Thus Pybus and Whitehead (44) found that the sera of rabbits immunized
against mouse carcinoma had a harmful effect in vitro, not only upon
carcinoma cells, but also upon mouse heart and kidney cells.

They also

found that the serum of a rabbit that had been injected with human carci¬
noma supported the growth of carcinomatous cells from mice, although not
as well as did normal rabbit serum.

The growth of normal mouse tissue

was also inhibited by the same antiserum.

Morelli (33, 40) and Witebsky

and Morelli (56) were unable to confirm a claim (Lehmann-Facius (27)) for
the separation of a specific antigen for tumor.

However, they did find

that antisera produced by the injection of suspensions of "bone sarcoma"
reacted with human extracts of sarcoma and carcinoma, and less positively
with normal tissues.

After adsorption with normal extracts, only tumor

antibodies remained in the serum; all antibodies were gone after subse¬
quent adsorption with tumor extracts.

Phelps (43) found that both sar¬

coma cells and normal spleen cells were killed by antiserum to the Jensen
rat sarcoma; spleen antiserum behaved the same way.
there was no specific cancer antiserum.

He concluded that

Hirzfeld and Halber (21) pro¬

duced complement-fixing and precipitin antibodies by injecting rabbits

Intravenously with extracts of tuberculous caseous tissue, purulent material,
necrotic tissue from infarcts, and malignant tissue.

The antibodies re¬

acted with all the antigens, and it was suggested that tumor antibodies
are the result of necrotic material present in most malignant tissues,
rather than of any malignant antigen per se.

Dmachowski (8) obtained

rat antiserum which reacted (complement-fixation) with heated tumor anti¬
gen, and also, although to a lesser degree, with extracts of normal rat
tissue.

Sera of rabbits immunized against extract of normal rat muscles

were found to contain antibodies which fixed complement with rat tumor
even more strongly than with the original antigen.

D*Alessandro et al

(4) are also cited as obtaining reactions between antiserum to the Jensen
sarcoma and extracts of normal organs.

Woodhouse (58) came to the conclu¬

sion that there is no proof of the existence of specific carcinoma anti¬
gen.
Most of the disagreement of the two sets of investigations is ap¬
parently due to the presence of normal tissue antibodies in sera of ani¬
mals injected with extracts of malignant tissue.

It would seem likely

that some normal tissue inevitably is mixed with the tumor antigen, the
separation of pure malignant tissue from normal tissue being difficult.
Evidence has accumulated indicating that the species antibodies, pro¬
duced by concomitant injections of contaminating normal tissue mixed
with the tumor antigen, may be separated from the malignant cells’ anti¬
bodies, and are not formed in response to pure malignant antigen.
Lumsden (31) found that the antibodies which were toxic to cancer
cells were present in the euglobulin fraction of the antiserum, while
the species antibodies were contained in the pseudoglobulin. Yiitebsky
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and Poplau (57) concluded that suspensions of saline extracts of carcinoma
contained three separate antigens - carcinoma, blood, and non-specific.
They found that while carcinoma antiserum may react with normal organ ex¬
tracts, this may be inhibited by lecithin, while the reactivity with mal¬
ignant tissue extracts remained unchanged.

The antibody adsorption exper¬

iments of Morelli, and Witebsky and Korelli, cited above, also indicate
the separate identities of the species and malignant antibodies. Friedwald
and Kidd (9), using complement-fixation tests, found that the sera of
rabbits carrying V2 carcinoma reacted with normal tissue extracts, but
reacted much more strongly with extracts of V£ carcinoma.

Furthermore,

they showed that heat abolishes the reaction with the normal tissue ex¬
tracts, as well as with heterologous tumor antigens, while the reaction
with the homologous tumor remained unchanged.

This antibody was distin¬

guishable from the antibody to the papilloma virus.
Mann and Welker (34) suggested that contaminating species antibodies
were due to the presence of blood mixed with the tumor antigen.

They suc¬

ceeded in preparing antisera free from contaminating species antibodies by
adsorbing the tumor antigen on alumina and injecting the suspension intra¬
muscularly into rabbits.

’With this method, the antibodies formed in re¬

sponse to the contaminating blood antigens disappeared in one to six months
leaving only tumor antibodies.

This was probably due to the fact that

blood antigen was present in much smaller quantities than the tumor, and
was rapidly exhausted from the intramuscular depots of the alumina mixture,
while appreciable amounts of malignant antigen remained.

As a result,

blood protein antibody production ceased sooner, thereby permitting these
antibodies to disappear while only tumor antibodies remained in force.
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These latter antibodies were demonstrated by precipitin reactions with
an autolyzed antigenic extract; no reaction was obtained with blood pro¬
tein after one to six months and normal autolyzed tissue extracts did not
react either with the antisera.

In addition, the antisera reacted with

a significant number of sera from cancer patients, and not with sera of
control cases, thus furnishing a basis for a useful diagnostic test.
The use of alumina as an adsorbent had previously been described
by Marshall and Welker (35) in 1913*

Jacobs (22+) and Seibert (46) demon¬

strated that the precipitinogenic power of certain antigens was markedly
increased after adsorption with alumina.

In 1933, Hektoen and Welker

(16) caused the satisfactory formation of precipitins in the rabbit after
one intramuscular injection of antigen adsorbed on aluinina.

In 1934, the

same authors (17) showed that when several antigens were adsorbed on alumi¬
na, the antibodies formed disappeared from the circulating blood at dif¬
ferent times, apparently in proportion to the amount of respective antigen
injected.

Spinka and Weichselbaum (52) applied this technique to tissue

antigens.

They immunized rabbits with ground kidney and liver adsorbed

on alumina and found that precipitins for blood proteins disappeared in
one to two months, at which time the antisera continued to react with
autolysates of the antigenic extract.

The work of Mann and Welker appears

to be an extension of this, using malignant tissue as an antigen.

(
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Material and Methods
Briefly stated, the methods were as follows:

an extract, prepared

from metastatic thyroid carcinoma, was adsorbed on alumina and injected
intramuscularly into four rabbits.

Their venous blood at intervals of 3-4

weeks was tested with normal human serum for the presence of blood anti¬
bodies.

When these had disappeared, the antiserum was then tested with

autolyzed extract of the original antigen to determine the presence of
antibodies to this preparation.

The sera of the rabbits that were shown

to be free of blood antibodies and to contain antibodies to the autolyzed
extract (presumably tumor cell) were then tested with the sera of patients
with and without malignant disease.
Preparation of Antigen:
(1) Tissue.

Great difficulty was encountered in procuring a sufficient

amount of comparatively "pure culture" of malignant tissue; that is, tissue
that is essentially free of normal tissue, without infection, and with a
minimum of necrosis.

The amount of such material obtainable from surgical

specimens was negligible.

It was finally possible to obtain satisfactory

antigen from the autopsy material provided by a patient with carcinoma of
the thyroid with extensive generalized carcinomatosis.

The Liver of this

patient was heavily infiltrated with metastases, and from one slice sixty
grams of aLmost pure malignant tissue were obtained after careful dissec¬
tion (see Appendix).

Lundy (33) has reported that metastatic and autopsy

material furnished good antigens for complement-fixation reactions, and
Morelli (39) had, in fact, used abdominal metastases from thyroid carcinoma
to produce satisfactory antibodies in the rabbit.
After thoroughly dissecting away all normal tissue, the tumor tissue
was ground in a meat grinder and washed with saline to remove as much blood

as possible.

It was then ground in a ball mill with some saline and a

small amount of toluol as a preservative for about sixty hours and
strained through a cheesecloth.

The filtrate was washed with saline in

a centrifuge until the supernatant was biuret negative.

The ground tis¬

sue was taken up in saline, a few drops of merthiolate, 1:1000, was added,
and then it was treated with enough alumina to precipitate all the sus¬
pension.
(2) Alumina:

The alumina was prepared by slowly adding ~L% ammonium

hydroxide to a liter of 1% ammonium alum, at room temperature, until the
liquid yielded a faint odor of ammonia.

The resulting precipitate was

washed several times by decantation with distilled water, filtered, and
washed until the filtrate was fairly free from salts.

It was then trans¬

ferred to a glass cylinder and washed again by decantation until 500 cc,
of the supernatant, evaporated to dryness, left practically no residue.
After the tumor extract had been adsorbed on to the alumina, this
was taken up with as much saline as was convenient to permit the use of
a 17 gauge needle, and injected into the thigh muscles of four rabbits,
twenty to thirty cubic centimeters into each rabbit, in depots of one to
two cubic centimeters.
A portion of the tumor extract was not precipitated with alumina,
but set aside for tests against the rabbit antisera.

This was autolyzed

by suspending in three times its volume of saline and incubating for
twenty-four hours at 3S°C.

The resulting suspension was then diluted

with saline up to 1:1000.
Technique of Tests: The precipitin tests were carried out in tubes made
by sealing off 7 mm. bore glass tubing.

Two tenths of a cubic centimeter

-9of each serum were all that were required for each test, one serum being
slowly layered over the other.

The tubes were left at room temperature

for an hour, and a positive reaction determined by the presence of a
thin annular precipitate at the interface between the two sera.
Preliminary experiments were necessary in order to perfect the
technique, as it is not difficult to obtain both false negatives and
false positives by faulty technique.

Factors leading to a false positive

reaction include, first of all, dirty tubes and pipettes.

A cloudy emul¬

sion easily forms on the glassware, and this may be washed down along
the sides bjr the test serum, settle at the interface, and give a false
positive.

Although the tubes were left in alkali overnight, rinsed with

cleaning solution, and thoroughly washed with water under suction, it
was found advisable not to use the same tube more than three times at
most.

Another source of error lies in the fact that although all sera

from patients or rabbits were drawn in the fasting state, they were oc¬
casionally cloudy.

The appearance in the precipitin tube of the sudden

transition from the cloudy lower layer to clear upper layer almost re¬
sembled a positive reaction, and frequent controls with saline were neces¬
sary as a check.

Occasionally droplets of oil would collect just above

the interface; these may be distinguished from a true positive because
they do not assume an annular configuration, and appear above rather than
at the interface.
False negative readings are avoided by reading the tubes with a
strong light shining through, preferably against a dark background. Day
light, or light of ceiling fixtures, are not sufficiently powerful; a
desk lamp produces a satisfactory amount of illumination, and this was
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used.
The experimental readings (rabbit antiserum with normal human serum
or with antigen) were done in duplicate, and in every case consistent re¬
sults were obtained.

The sera for the clinical readings (rabbit antiserum

against patient's sera) were obtained from the sera sent to the surgical
chemistry laboratory for analyses.
in the fasting state.

These had all been withdrawn under oil

In this way, the diagnoses of the patients were

unknown to the experimentor, and were learned only after the reading had
been recorded.

These determinations were not done in duplicate because

of the limitation in the amount of serum.
Results
The sera of two of the rabbits injected were tested with normal hu¬
man serum for the presence of antibodies of human blood protein.

These

tests were performed by layering the human serum, in dilutions of 1:10 1:1000, over the rabbit antisera as described above.

The data in Table I

demonstrate that precipitins to normal blood proteins disappeared from the
sera of both rabbits about three months after injection of the antigenic
preparation.

This interval was found to be one to two months by Spinka

and Wechselbaum (52), and one to six months by Mann and Welker (34).

The

remaining two rabbits died of sepsis a few days after injection (revealed
by autopsy).
Having demonstrated the disappearance of contaminating blood anti¬
bodies, the antiserum next was tested with the original autolyzed extract
to detect the presence of antibodies for this preparation.

Of the two

rabbits sera tested one gave a positive precipitin reaction with the ex¬
tract, while the other did not.

Simultaneous controls of normal human
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serum, layered over undiluted human serum, to check on error in technique,
were negative, as were reactions of diluted antigen layered over normal
human and normal rabbit sera (Tables I and II).
It may be mentioned that the literature reveals that not many rabbits
respond with antibody production to the injection of malignant tissue.
Mann and Welker state,

"The percentage of rabbits producing powerful pre¬

cipitin antiserum when immunized with malignant tissue is much smaller
than the percentage that responds when immunized with normal serum proteins".
Using thyroid tumor, Morelli (39) obtained antibodies in four of seven rab¬
bits, and likewise Hirszfeld and Kalber (20) found antibodies in only 1020$ of rabbits injected with alcoholic extracts of cancer tissue.
Following the apparent demonstration of predpitins to malignant tis¬
sue in Rabbit #1, the antiserum of this rabbit was then tested with those
of patients.

In the first tests the antiserum was diluted 1:10; however,

in the course of the experiments, the rabbit died^and it was necessary to
dilute to 1:50 its remaining serum so that a few additional tests could
be performed.

It was found that although 1:10 was more satisfactory, posi¬

tive results were obtainable with the more dilute antiserum.
Five of 10 patients with carcinoma proved by biopsy in almost all
cases reacted positively with the antiserum.

A total of 13 tests were per¬

formed, with 7 positive results, three patients being tested with both di¬
lutions of antiserum.

Four of 7 tests with the 1:10 dilution and 3 of 6

with the 1:50 dilution were positive (Table III).
One patient with a benign tumor (meningocytic meningioma) also gave

^Autopsy revealed a fibrinous gray exudate over the epicardium, some cloudy
white fluid in the pericardial cavity, a
flabby myocardium, and a large,
dilated stomach.

■*-

TABLE I
Disappearance of Normal Human Blood Protein Precipitins from Two Rabbits
Injected with Antigen (Metastati c Thyroid Carcinoma Adsorbed on Alumina).

A.

Rabbits No. 1 and 2

Injected 11-13-41
Normal human serum
1:10

1:1000

1:100

12“21=41

Undiluted antiserum

+

+

+

1-24=42

Undiluted antiserum

+

+

+

2-12-42

Undiluted antiserum

-

-

B.

Controls

1-24=42

Undiluted normal

-

-

2-12-42

human serum

-

-

TABLE II
Positive Precipitin Reaction in One of Two Rabbits Follovdng Disappearance
of Human Blood Protein Precipitins.
Autolyzed Antigenic Suspension

1:10*
Rabbit No. 1 (undiluted)

?

Rabbit No. 2

»

?

Normal Rabbit

11

Normal Human

"

N.B.

1:100

1:1000

+

-

-

All reactions in above tables were performed in duplicate.

*The suspension was too thick at this dilution for a satisfactory reading
to be made.
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Biopsy not reported, but gross appearance at operation was that of unresectable carcinoma.
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a positive reaction.
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This patient had had a gastrectomy about 2 years

earlier for a presumed gastric carcinoma, which, however, on pathologi¬
cal study proved to be a benign ulcer.
In all 10 patients without evidence of malignant disease were
tested, and they were negative; 7 with 1:10 dilution of the antiserum,
and 4 with 1:50 dilution (one patient was tested with both dilutions).
These results appear in Table IV.
Because some workers had reported positive antibody-antigen reac¬
tions between tumor extracts and the sera of cancer patients, the
autolyzed extract was tested against the sera of 9 patients with malig¬
nant disease, by layering over these the 1:100 dilution of antigen. All
of these were negative (Table III).
Discussion
The amount of data available from the present experiments are
hardly sufficient to be considered as a confirmation of the work of Mann
and Welker although the results tend to lean that way.

The few positive

reactions which were obtained with the human sera were all in tumor pa¬
tients, and the results thus appear to justify further work.
Assuming slight statistical significance to the results, the simplest
explanation would be that upon which the theory of the experiment is
based - the injection of the alumina-precipitated malignant tissue re¬
sulted in the production of precipitin antibodies in the rabbit, which
cause the positive reaction with the original antigenic suspension. The
reaction between the serum of carcinoma patients and the rabbit antiserum
would, necessitate the assumption of the circulation of malignant antigen
in the patient's blood.

Some evidence for this may be found in the work

TABLE IV
Reactions of Sera of Non-Carcinomatous Patients with Rabbit Antiserum

Case
No.

Patient

Age

Sex

Hosp. No.

Diagnosis

React, with antiserum
1:10
1:50

1

A. D.

72

M

B24307

Duodenal ulcer

2

H. K.

65

M

B24336R

Duodenal ulcer

3

C. C.

45

F

A29221

Pulmonary tbc.
Small bowel obst.
due to post-cp
adhesions

4

E. M.

a

F

A23010

Cystitis
Chronic P. I. D.

5

E. D.

13

F

A25566

Perforated appendix -

6

M. W.

69

M

B24849

Perforated gall
bladder

7

I. W.

23

M

8

C. J.

70

M

B13207

9

J. s.

44

M

67089

10

L • 0»

16

F

B15568

Normal

-

Perforated appendix Duodenal ulcer
Nephrotic stage of
glomerulonephritis
Pneumococcal peri¬
tonitis
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of Hirszfeld and his associates (22) who found that the serum of rabbits
immunized with human tumor extracts reacted with extract of livers of
patients with gastric carcinoma.

This v/as interpreted as implying the

impregnation of the liver with carcinomatous substances, a sort of "bio¬
chemical metastasis".

Breinl and his associates are cited as obtaining

similar results (6).
Other diagnostic tests based upon this principle have been described.
Gruskin (14), using embryonal cells from fetal mammals injected intraperi toneally into the experimental animals, obtained an antiserum which
reacted with carcinoma serum.

Peretz and Newler (42) used a complement-

fixation test with carcinoma serum as antigen and the sera of rabbits im¬
munized with carcinoma extracts as the source for antibody.

With this

technique, these workers obtained 75/S positives with carcinoma patients,
and 7.6$ false positives.

Fairly good results have been obtained with

the urine of carcinoma patients as the source of antigen (5), and this
implies the presence of carcinoma antigen in the circulating blood. Against
these latter results are the theoretical objection of the difficulty of
the antigen, presumably of large molecular weight, to pass through the
renal filter, as well as the experimental results of Sobotka and Bloch
(50) whose work indicates that the only chemical difference between the
urine of carcinoma and non-carcinoma patients lies in a higher cholesterol
level of the former.
Although the above explanation might be appealing, several serious
objections may be raised.

The precipitin reactions were carried out with

1:50 dilution of the antiserum.

According to Zinsser and Bayne-Jones (3),

precipitin reactions as known at present, are positive only in low dilu-
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tions of antiserum, with 1:20 mentioned as a limiting figure.

This would

suggest that all the positive results were due to faulty technique.

On

the other hand, the paper of Mann and Welker mentioned positive precipitin
reactions between antiserum and normal human blood proteins with dilutions
of the former as high as 1:100,000.
The possibility that the precipitins in the rabbit serum were anti¬
bacterial and not anti-malignant must be considered - especially as two
rabbits died within a few days after injection with overwhelming infec¬
tions despite the use of merthiolate.

This possibility is always present

when malignant, slightly necrotic (see Appendix) tissue is used.

However,

while the reaction between antigen and antiserum would be explainable, it
would be difficult to account for the positive reaction between the anti¬
serum and carcinoma patients' sera in view of the negative results with
the controls.

More difficult to answer is the work of Hirszfeld and Halber

(21) indicating that the antigenic properties of malignant tissue are in
common with those of all necrotic tissue.

It may be pointed out, however,

that several of the negative controls suffered from acute gangrenous pro¬
cesses, which, theoretically, should have caused the liberation of as much
"necrotic antigen" as some of the carcinoma patients.
The second series of tests, using the antigenic suspension and pa¬
tients' antisera, was based upon the possible presence of antibodies to
malignant tissue in the patient's blood, rather than circulating malig¬
nant antigen.

These tests were all negative.

However,

several diagnostic

tests for carcinoma, based upon this supposition, have been devised by others.
Some of these have resulted in significant, although not clinically useful,
results.

The technique has usualljr been a complement-fixation test, rather
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than precipitin, with tumor extract (usually alcoholic, and occasionally
cholesterolized) as antigen and the patients' sera as antibody.
In 1903, Simon and Thomas (49) used breast tumor emulsion as antigen
for complement-fixation tests and obtained suggestive results (65^ positive
in 37 malignant cases, and 1$ positive in 50 controls).

Fry (10, 11) used

a saline emulsion of the saline insoluble, acetone and alcohol soluble,
fraction of malignant tissue and obtained about 75!^ correct results.

Other

workers have obtained satisfactoryr results with complement-fixation or
flocculation tests based upon the above theory (15, 26, 37, 41, 45, 55).
Less satisfactory results have been obtained by others (13, 28, 36, 47, 43,
53).
It is evident that these problems are in an unsettled state, and de¬
serve further exploration.

The work reported here, though suggestive, is

of too small volume to help to clarify the subject.

Summary and Conclusions
1.

Four rabbits were injected intramuscularly with human metastatic thyroid
carcinoma adsorbed upon alumina.

Two rabbits died of infection a few

days after their injections.
2.

Precipitins to normal human blood serum, demonstrated in the sera of the
two surviving rabbits, disappeared three months after the injection.

3.

The serum of one of the two rabbits gave a positive precipitin reaction
with the autolyzed antigen after the human blood precipitins had disap¬
peared.

4.

The serum of this rabbit gave a positive precipitin reaction with the
sera of 5 of 10 patients suffering with malignant disease.

Of 13 tests

.
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performed on such patients, 7 were positive.

The presence or absence

of clinically demonstrable metastases did not appear to affect the re¬
sult.
5.

Negative reactions with the antiserum were obtained with serum of all
10 people without demonstrable cancer.

6.

The single case with a benign tumor (meningioma) reacted positively.

7.

Precipitin reactions between all sera of 9 carcinomatous patients and
the autolyzed extract were negative.

8.

The small number of experimental animals and tests used in this work
prevent any definite conclusions from being drawn.

9.

The theoretical aspects and other experimental work in this field are
discussed.

■17-

Appendix
Excerpts from Autopsy Protocol of R. W., Hosp. No. B15824, Autopsy No. 5548.

Anatomical Diagnosis
"Carcinoma of thyroid with metastases to mediastinal, axillary, cervi¬
cal, retroperitoneal and inguinal lymph nod.es, internal mammary veins, epicardium, lungs, liver, left kidney and vertebrae.
"The thyroid has the usual butterfly shape and weighs 28 grams.
ternal color is much lighter red-brown than usually encountered.

Ex¬

When sec¬

tioned it is discovered that about 40-50$ of the parenchyma is replaced by
firm gray, gritty tissue.
".... in all, the normal thyroid acini have been almost completely re¬
placed by neoplastic tissue.

The latter is composed of cells with large,

oval or round variable-sized vesicular nuclei which occasionally contain
nucleoli; cytoplasm is faintly eosinophilic,

scant, and faintly granular.

LUtotic figures are present but not numerous, there seldom being more than
two in each high dry (X450) field.

For the most part these cells occur in

solid masses or sheets, without distinctive pattern.

Not infrequently, how¬

ever, small well'-formed acini are found in the neoplastic tissue.

Dense

fibrous tissue surrounds all foci of the malignant cells.
"The liver weighs 3900 grams.

Its surface is studded with many large

and small discrete and confluent umbilicated nodules of gray-white tissue ...
In section, the accumulations of firm white tissue are found to occupy an
estimated 50-60$ of the bulk of the liver.

Centrally, the foreign tissue

foci are found to be softened with the result that cream-like material can
be scraped away on the knife blade.

18
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"Large sheets and masses of tumor cells are scattered about in a fibrous
stroma containing proliferating bile ducts ... Several small malignant tissue
implants removed from the main large nodules are seen scattered throughout
the parenchyma.
a central vein."

One small group of neoplastic cells occupies the lumen of
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